This article may meet Wikipedia's criteria for speedy deletion as a page that was previously deleted via a deletion discussion, is substantially identical to the deleted version, and any changes do not address the reasons for which the material was deleted. See the previous discussion .See CSD G4. If this article does not meet the criteria for speedy deletion, or you intend to fix it, please remove this notice, but do not remove this notice from pages that you have created yourself. If you created this page and you disagree with the given reason for deletion, you can click the button below and leave a message explaining why you believe it should not be deleted. You can also visit the talk page to check if you have received a response to your message. Note that this article may be deleted at any time if it unquestionably meets the speedy deletion criteria, or if an explanation posted to the talk page is found to be insufficient. Note to page author: you have not edited the article talk page yet. If you wish to contest this speedy deletion, clicking the button above will allow you to leave a talk page message explaining why you think this article should not be deleted. If you have already posted to the talk page but this message is still showing up, try purging the page cache . Administrators: check links, talk, history (last), and logs before deletion. Consider checking Google. This page was last edited by Sadustu Tau (contribs | logs) at 15:57, 22 May 2024 (UTC) (4 seconds ago) |
Company type | Limited company |
---|---|
Industry | Pharmaceutical company |
Founded | 1956 |
Founder | Abdul Khaleque Khan |
Headquarters | 30, New Eskaton Rd., Hatirjheel, Dhaka-1000 |
Area served | Asia, Africa, Middle East, Central America and Oceania |
Website | www |
Opsonin Pharma Ltd. (OPL) or simply Opsonin is a Bangladeshi pharmaceutical company headquartered at New Eskaton, Hatirjheel, Dhaka. Opsonin is one of the leading pharmaceutical companies in Bangladesh, established in 1956. [1] As of 2023, Opsonin had the sixth-highest market share in the pharmaceuticals industry with sales worth BDT 13.91 billion and a market share of 4.6pc, according to IQVIA. [2] The company exports to 25 countries across Asia, Africa, the Middle East, Central America and Oceania. [3]
Bangladesh Export Import Company Limited, commonly known by its trade name BEXIMCO, is a Bangladeshi multinational conglomerate holding company, headquartered in Dhaka, Bangladesh. It was founded in the early 1970s.
The pharmaceutical industry in India was valued at an estimated US$42 billion in 2021 and is estimated to reach $130 billion by 2030. India is the world's largest provider of generic medicines by volume, with a 20% share of total global pharmaceutical exports. It is also the largest vaccine supplier in the world by volume, accounting for more than 60% of all vaccines manufactured in the world. Indian pharmaceutical products are exported to various regulated markets including the US, UK, European Union and Canada.
Rohto Pharmaceutical Co., Ltd. is a multinational corporation in fast-moving consumer goods and pharmaceutical corporation headquartered in Ikuno-ku, Osaka, Japan. with revenues steadily increasing from ¥95,619 million in 2006 to ¥120,292 million in 2011. Skin care contributes to 61.3% of the revenues, while Eye Care contributes to 21% of their sales.
Square Pharmaceuticals Ltd. is a Bangladeshi multinational pharmaceutical company. It was founded in 1958 by Samson H. Chowdhury along with three of his friends PK Saha, Kazi Harunur Roshid and Radhabinod Rai as a private firm. It went public in 1991 and is listed on the Dhaka Stock Exchange and on the Chittagong Stock Exchange Square Pharmaceutical started to export different antibiotics and medicine across the world from 1987. Now it exports its medicine to 36 countries of the world.
Endo International plc is an American Irish-domiciled generics and specialty branded pharmaceutical company that generated over 93% of its 2017 sales from the U.S. healthcare system. While Endo's management, operations, and customers are almost exclusively U.S.–based, in 2013 Endo executed a corporate tax inversion to Ireland to avoid U.S. corporate taxes on their U.S. drug sales, and to avail of Ireland's corporate tax system.
IQVIA, formerly Quintiles and IMS Health, Inc., is an American Fortune 500 and S&P 500 multinational company serving the combined industries of health information technology and clinical research. IQVIA is a provider of biopharmaceutical development, professional consulting and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including investment strategy and management consulting services. It has a network of more than 88,000 employees in more than 100 countries and a market capitalization of US$49 billion as of August 2021. As of 2023, IQVIA was reported to be one of the world's largest contract research organizations (CRO).
Hikma Pharmaceuticals plc is a British multinational pharmaceutical company with headquarters in London, UK that manufactures non-branded generic and in-licensed pharmaceutical products. It was founded by Samih Darwazah in Amman, Jordan in 1978. It is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index.
Beximco Pharmaceuticals Ltd, also known as Beximco Pharma is a Bangladeshi multinational pharmaceutical company. It is a part of Bangladesh Export Import Company Limited (BEXIMCO).
The ACME Laboratories Ltd is a pharmaceutical company based in Bangladesh. It is part of the ACME Group of Companies. Mizanur Rahman Sinha is the managing director and largest shareholder of the company and Nagina Afzal Sinha is the chairperson.
Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, that manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) in more than 100 countries across the globe. It is the largest pharmaceutical company in India and the fourth largest specialty generic pharmaceutical company in the world. The products cater to a vast range of therapeutic segments covering psychiatry, anti-infectives, neurology, cardiology, diabetology, gastroenterology, ophthalmology, nephrology, urology, dermatology, gynecology, respiratory, oncology, dental and nutritionals.
A contract manufacturing organization (CMO), more recently referred to as a contract development and manufacturing organization (CDMO) to avoid the acronym confusion of Chief Medical Officer or Clinical Monitoring Organization in the pharma industry, is a company that serves other companies in the pharmaceutical industry on a contract basis to provide comprehensive services from drug development through drug manufacturing. This allows major pharmaceutical companies to outsource those aspects of the business, which can help with scalability or can allow the major company to focus on drug discovery and drug marketing instead.
Julphar is an Emirati pharmaceutical manufacturer in the Middle East. Headquartered in Ras Al Khaimah, United Arab Emirates, the company employs more than 5,000 people and distributes its pharmaceutical products internationally. The company has three divisions — General Medicines, Julphar Diabetes Solutions and Julphar Life. In 2018, the company was ranked as the number one pharmaceutical manufacturer in the UAE.
Glenmark Pharmaceuticals Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, India.
Ajanta Pharma Limited, also known by the acronym APL, is a multinational company based in India engaged in development, manufacturing, and marketing of pharmaceutical formulations. It has a presence in India, the United States, and about 30 other countries in Africa, South East Asia, West Asia, and CIS. It was established in 1973.
Jazz Pharmaceuticals plc is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States. One of the company's considerable products is the United States Food and Drug Administration (FDA) approved drug Xyrem, the sodium salt of the naturally occurring neurotransmitter γ-Hydroxybutyric acid (GHB). In 2017, net product sales of Xyrem were $1.187 billion, which represented 74% of the company's total net product sales. In 2019, Jazz was granted FDA-approval to market Sunosi with indications for treating excessive daytime sleepiness (EDS) in narcolepsy as well as obstructive sleep apnea (OSA). In 2022, it was announced that Axsome Therapeutics would be acquiring Sunosi from Jazz Pharmaceuticals.
Horizon Therapeutics was a biopharmaceutical company focused on researching, developing, and commercializing medicines that address critical needs for people impacted by rare and rheumatic diseases. Horizon primarily markets products in the United States, which represented 97% of Horizon's 2019 worldwide sales. Amgen acquired the company in October 2023.
CSL Vifor is a global specialty pharmaceuticals company in the treatment areas of iron deficiency, dialysis, nephrology & rare disease. It is headquartered in Switzerland and consists of CSL Vifor, Vifor Fresenius Medical Care Renal Pharma (VFMCRP) and Sanifit Therapeutics.
Square Group is a Bangladeshi diversified multinantional conglomerate based in Dhaka. Samuel S Chowdhury is the chairman and Tapan Chowdhury is managing director of Square Group. Square Group has 60 thousand employees.
Metro Group is a Bangladeshi diversified conglomerate based in Dhaka. It is the parent company of Best Holding Limited which owns Le Meridien Dhaka.